Venture Partners Ii Lp Scale is 10% at Orexigen Therapeutics, Inc. (OREX). They have made 7 open-market trades across 2 companies since 2007, most recently 2011-08-02.
CIK 0001314703
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.8M since 2011, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HZNP | BUY | 2011-08-02 | 2011-08-04 | $9.00 | $2.8M | -16.8% | +0.4% | +0.4% |
| OREX | SELL | 2007-11-21 | 2007-11-21 | $15.00 | $2K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-19 | 2007-11-20 | $15.02 | $42K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-16 | 2007-11-19 | $15.66 | $476K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-16 | 2007-11-19 | $15.53 | $251K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-15 | 2007-11-16 | $15.58 | $23K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-15 | 2007-11-16 | $15.59 | $221K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.